Griffin Update, page-3

This is how I look at it --

Piper has UNS making 550MM off Hikma, Lovenox, and Sanofi WI by 2019.

Griffin said there are 12 More in discussions --

"Ongoing discussions with pharmaceutical companies are real. Unlike announcements in the past that didn’t always yield new business in the subsequent months, the 12 or so that were referenced at the meeting were evaluated internally and vetted by outside counsel to support the strategic financing initiative. Our impression is that the short list is an honest assessment of new, potentially near-term business."

Lets say the averaged gross income per each of those contracts is just $50MM per year which combine gives you $600MM.

Now add in the $550MM from the Piper Projections and that gives you $1.15 Billion in sales.

Sleep well ....